Bringing the Oncology Community Together

Supercomputer Network Allows for Faster Genomic Analysis

Andrew J. Roth
Published Online: Thursday, October 4, 2012
Dr. Patrick Soon-Shiong

Patrick Soon-Shiong, MD

A new supercomputer-based network will allow physicians to transfer and analyze genomic data more rapidly than standard methods, announced Patrick Soon-Shiong, MD, Chairman of NantHealth and the Chan Soon-Shiong Institute for Advanced Health, on October 3.

“It currently takes approximately two months and tens of thousands of dollars to perform the sequencing and analysis of a single cancer patient’s genome," said Soon-Shiong. "We needed a national supercomputing infrastructure that brings genomic medicine into clinical practice. By placing supercomputers in the hands of physicians, that need is now a reality.”

The high-speed network was built through the collaboration of multiple technology and healthcare companies and organizations with the intent to provide physicians the ability to analyze genetics, risk, and costs of multiple treatment options, in an accelerated timeframe.

In an analysis of the system, 6017 tumor and germline exomes from 3022 patients were transferred and processed by the supercomputer using a fiber network. Samples for the analysis primarily represented solid tumors. In total, 96,512 gigabytes of genetic information were analyzed.

The test of the system measured the total time needed for transferring the data and analyzing the results. In general, the overall transfer speed for each sample was 17.4 seconds and each analysis was completed in approximately 47 seconds. 

“Doctors will finally be able to provide higher-quality treatment in a dramatically more efficient, effective, and affordable manner," Soon-Shiong said in a release. "This revolution in healthcare is long overdue - converging 21st century medical science with 21st century technology.”

NantHealth built the supercomputing network in collaboration with Blue Shield of California, the Chan Soon-Shiong Institute for Advanced Health, the National LambdaRail, Doctors Helping Doctors, Verizon, Bank of America, AT&T, Intel, and Hewlett-Packard.

Related Articles
Emerging Breakthroughs in Cancer Care: Toward a Revolution?
Medicine is undergoing a revolution that will transform the practice of healthcare, including oncology.
Next-Generation Targeted Therapies in NSCLC
In this segment, panelists discuss the number of early-phase clinical trials that have demonstrated impressive efficacy for next-generation ALK and EGFR inhibitors for patients with non-small cell lung cancer.
Targeted Therapies Usher in a New Era in CLL: Wierda Discusses Key Facets of Emerging Agents
The approval of the first small-molecule, targeted therapy for patients with chronic lymphocytic leukemia (CLL) launches a new era that promises to transform management of the disease, yet significant challenges in translating research advances into improvements in long-term outcomes remain
Most Popular Right Now
More Reading
External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc
OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives


About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.